A. Couret, V. Gardette, A. Renoux, M. Lapeyre-Mestre
{"title":"CO3.3--法国阿尔茨海默病及相关疾病特效药报销变化的影响:FRA-DEM队列分析","authors":"A. Couret, V. Gardette, A. Renoux, M. Lapeyre-Mestre","doi":"10.1016/j.jeph.2024.202409","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517428,"journal":{"name":"Journal of epidemiology and population health","volume":"57 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CO3.3 - Impact des modifications du remboursement des médicaments spécifiques de la maladie d'Alzheimer et maladies apparentées en France : analyse de la cohorte FRA-DEM\",\"authors\":\"A. Couret, V. Gardette, A. Renoux, M. Lapeyre-Mestre\",\"doi\":\"10.1016/j.jeph.2024.202409\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":517428,\"journal\":{\"name\":\"Journal of epidemiology and population health\",\"volume\":\"57 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of epidemiology and population health\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jeph.2024.202409\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of epidemiology and population health","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.1016/j.jeph.2024.202409","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
CO3.3 - Impact des modifications du remboursement des médicaments spécifiques de la maladie d'Alzheimer et maladies apparentées en France : analyse de la cohorte FRA-DEM